Skip to content
2000
image of Effects of Breast Milk or Supplemented Formula Milk on Fecal Metabolomic Profile

Abstract

Breast milk is the best option for the nutritional needs of an infant. In situations where breastfeeding is contraindicated, donor human milk and formula milk are suggested as alternatives. This study highlights findings from two studies that evaluated how different dietary patterns (standard formula, post-biotic fermented formula, and breast milk) affected the intestinal microbiota and metabolome of late preterm and full-term infants. The metabolome of late preterm newborns showed a higher presence of metabolites-such as azelaic acid, N-acetylglucosamine-6- sulfate, and 13(S)-hydroperoxylinolenic acid-in those fed postbiotic-fermented formula, similar to breastfed full-term newborns. The fecal metabolites of breast milk and substitute feeding systems are comparable in these preliminary studies, confirming the effectiveness of formula preparations as breast milk substitutes. Furthermore, newborns fed with postbiotic-supplemented formula or breast milk had several similarities in fecal metabolites. The addition of postbiotics to formula milk appears to be more efficient than standard formula milk and is considered a better alternative to breast milk.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963341570250422095946
2025-04-28
2025-10-30
Loading full text...

Full text loading...

References

  1. Roggero P Liotto N Pozzi C Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formula. Nat. Commun. 2020 11 1 2703 10.1038/s41467‑020‑16582‑1
    [Google Scholar]
  2. Lewis Z.T. Mills D.A. Differential establishment of bifidobacteria in the breastfed infant gut. Nestle Nutr. Inst. Workshop Ser. 2017 88 149 160 10.1159/000455399 28346936
    [Google Scholar]
  3. Vendt N. Grünberg H. Tuure T. Malminiemi O. Wuolijoki E. Tillmann V. Sepp E. Korpela R. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double‐blind, randomized trial. J. Hum. Nutr. Diet. 2006 19 1 51 58 10.1111/j.1365‑277X.2006.00660.x 16448475
    [Google Scholar]
  4. Perrone S. Laschi E. De Bernardo G. Giordano M. Vanacore F. Tassini M. Calderisi M. Toni A.L. Buonocore G. Longini M. Newborn metabolomic profile mirrors that of mother in pregnancy. Med. Hypotheses 2020 137 109543 10.1016/j.mehy.2019.109543 31901880
    [Google Scholar]
  5. Cerasani J Ceroni F De Cosmi V Human milk feeding and preterm infants' growth and body composition: A literature review. Nutrients 2020 12 4 1155 10.3390/nu12041155
    [Google Scholar]
  6. Davanzo R. Controversies in breastfeeding. Front. Pediatr. 2018 6 278 10.3389/fped.2018.00278
    [Google Scholar]
  7. Javot L. Pape E. Yéléhé-Okouma M. Barotte E. Divoux E. Gillet P. Gambier N. Scala-Bertola J. Intravenous single administration of amiodarone and breastfeeding. Fundam. Clin. Pharmacol. 2019 33 3 367 372 10.1111/fcp.12439 30471135
    [Google Scholar]
  8. Yapp P. Ilett K.F. Kristensen J.H. Hackett L.P. Paech M.J. Rampono J. Drowsiness and poor feeding in a breast-fed infant: Association with nefazodone and its metabolites. Ann. Pharmacother. 2000 34 11 1269 1272 10.1345/aph.10120 11098340
    [Google Scholar]
  9. Pistilli B. Bellettini G. Giovannetti E. Codacci-Pisanelli G. Azim H.A. Jr Benedetti G. Sarno M.A. Peccatori F.A. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding? Cancer Treat. Rev. 2013 39 3 207 211 10.1016/j.ctrv.2012.10.002 23199900
    [Google Scholar]
  10. Mitchell K.B. Fleming M.M. Anderson P.O. Giesbrandt J.G. Young M. Noble L. Reece-Stremtan S. Bartick M. Calhoun S. Dodd S. Elliott-Rudder M. Kair L.R. Lappin S. Lawrence R.A. LeFort Y. Marinelli K.A. Marshall N. Murak C. Myers E. Okogbule-Wonodi A. Roberts A. Rosen-Carole C. Rothenberg S. Schmidt T. Seo T. Sriraman N. Stehel E.K. Fleur R.S. Wight N. Winter L. Academy of Breastfeeding Medicine ABM clinical protocol #31: Radiology and nuclear medicine studies in lactating women. Breastfeed. Med. 2019 14 5 290 294 10.1089/bfm.2019.29128.kbm 31107104
    [Google Scholar]
  11. Gibson L. Porter M. Alcohol and tobacco use while breastfeeding and risk of autism spectrum disorder or attention deficit/hyperactivity disorder. J. Autism Dev. Disord. 2022 52 3 1223 1234 10.1007/s10803‑021‑05027‑3 33893938
    [Google Scholar]
  12. Metz T.D. Borgelt L.M. Marijuana use in pregnancy and while breastfeeding. Obstet. Gynecol. 2018 132 5 1198 1210 10.1097/AOG.0000000000002878 30234728
    [Google Scholar]
  13. Sachs H.C. Frattarelli D.A.C. Galinkin J.L. Green T.P. Johnson T. Neville K. Paul I.M. Van den Anker J. Committee On Drugs The transfer of drugs and therapeutics into human breast milk: An update on selected topics. Pediatrics 2013 132 3 e796 e809 10.1542/peds.2013‑1985 23979084
    [Google Scholar]
  14. Eidelman A.I. Schanler R.J. Johnston M. Landers S. Noble L. Szucs K. Viehmann L. Section on Breastfeeding Breastfeeding and the use of human milk. Pediatrics 2012 129 3 e827 e841 10.1542/peds.2011‑3552 22371471
    [Google Scholar]
  15. Guidelines on optimal feeding of low birth-weight infants in low- and middle-income countries. 2011 Available from: https://www.who.int/publications/i/item/9789241548366
  16. Daniels S. Corkins M. de Ferranti S. Golden N.H. Kim J.H. Magge S.N. Schwarzenberg S.J. Meek J.Y. Johnston M.G. O’Connor M.E. Stellwagen L.M. Thomas J.P. Ware J.L. Schanler R.J. Watterberg K.L. Aucott S.W. Benitz W.E. Cummings J.J. Eichenwald E.C. Goldsmith J.P. Poindexter B.B. Puopolo K.M. Stewart D.L. COMMITTEE ON NUTRITION SECTION ON BREASTFEEDING COMMITTEE ON FETUS AND NEWBORN Donor human milk for the high-risk infant: Preparation, safety, and usage options in the United States. Pediatrics 2017 139 1 e20163440 10.1542/peds.2016‑3440 27994111
    [Google Scholar]
  17. Embleton N.D. Jennifer Moltu S. Lapillonne A. van den Akker C.H.P. Carnielli V. Fusch C. Gerasimidis K. van Goudoever J.B. Haiden N. Iacobelli S. Johnson M.J. Meyer S. Mihatsch W. de Pipaon M.S. Rigo J. Zachariassen G. Bronsky J. Indrio F. Köglmeier J. de Koning B. Norsa L. Verduci E. Domellöf M. Enteral nutrition in preterm infants (2022): A position paper from the ESPGHAN committee on nutrition and invited experts. J. Pediatr. Gastroenterol. Nutr. 2023 76 2 248 268 10.1097/MPG.0000000000003642 36705703
    [Google Scholar]
  18. Stevens E.E. Patrick T.E. Pickler R. A history of infant feeding. J. Perinat. Educ. 2009 18 2 32 39 10.1624/105812409X426314 20190854
    [Google Scholar]
  19. Human milk banking: A global implementation framework. 2015 Available from: https://www.path.org/who-we-are/programs/maternal-newborn-child-health-and- nutrition/strengthening-human-milk-banking-resource-toolkit-0/
  20. Murphy K Curley D O'Callaghan TF The composition of human milk and infant faecal microbiota over the first three months of life: A pilot study. Sci. Rep. 2017 7 40597 10.1038/srep40597
    [Google Scholar]
  21. Bezirtzoglou E. Tsiotsias A. Welling G.W. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 2011 17 6 478 482 10.1016/j.anaerobe.2011.03.009 21497661
    [Google Scholar]
  22. Dominguez-Bello M.G. Costello E.K. Contreras M. Magris M. Hidalgo G. Fierer N. Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 2010 107 26 11971 11975 10.1073/pnas.1002601107 20566857
    [Google Scholar]
  23. Tsilingiri K. Rescigno M. Postbiotics: What else? Benef. Microbes 2013 4 1 101 107 10.3920/BM2012.0046 23271068
    [Google Scholar]
  24. Tsilingiri K. Barbosa T. Penna G. Caprioli F. Sonzogni A. Viale G. Rescigno M. Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model. Gut 2012 61 7 1007 1015 10.1136/gutjnl‑2011‑300971 22301383
    [Google Scholar]
  25. Fabiano V. Indrio F. Verduci E. Calcaterra V. Pop T.L. Mari A. Zuccotti G.V. Cullu Cokugras F. Pettoello-Mantovani M. Goulet O. Term infant formulas influencing gut microbiota: An overview. Nutrients 2021 13 12 4200 10.3390/nu13124200 34959752
    [Google Scholar]
  26. Szajewska H. Kołodziej M. Skórka A. Pieścik-Lech M. Infant formulas with postbiotics. J. Pediatr. Gastroenterol. Nutr. 2022 74 6 823 829 10.1097/MPG.0000000000003441 35258495
    [Google Scholar]
  27. Liang X. Li Y. Zhao Z. Ding R. Sun J. Chi C. Safety and efficacy of adding postbiotics in infant formula: A systematic review and meta-analysis. Pediatr. Res. 2024 95 1 43 51 10.1038/s41390‑023‑02813‑w 37700163
    [Google Scholar]
  28. Srinivasjois R. Gebremedhin A. Silva D. Rao S.C. Tessema G.A. Pereira G. Probiotic supplementation in the neonatal age group and the risk of hospitalisation in the first two years: A data linkage study from western australia. Nutrients 2024 16 13 2094 10.3390/nu16132094 38999842
    [Google Scholar]
  29. De Bernardo G. Sordino D. De Chiara C. Riccitelli M. Esposito F. Giordano M. Tramontano A. Management of NEC: Surgical treatment and role of traditional X-ray versus ultrasound imaging, experience of a single centre. Curr. Pediatr. Rev. 2019 15 2 125 130 10.2174/1573396314666181102122626 30387397
    [Google Scholar]
  30. De Bernardo G. Necrotizing enterocolitis: From diagnosis to therapy. Curr. Pediatr. Rev. 2019 15 2 67 10.2174/157339631502190722091754 31433747
    [Google Scholar]
  31. Suez J. Zmora N. Zilberman-Schapira G. Mor U. Dori-Bachash M. Bashiardes S. Zur M. Regev-Lehavi D. Ben-Zeev Brik R. Federici S. Horn M. Cohen Y. Moor A.E. Zeevi D. Korem T. Kotler E. Harmelin A. Itzkovitz S. Maharshak N. Shibolet O. Pevsner-Fischer M. Shapiro H. Sharon I. Halpern Z. Segal E. Elinav E. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 2018 174 6 1406 1423.e16 10.1016/j.cell.2018.08.047 30193113
    [Google Scholar]
  32. Newburg D.S. Ko J.S. Leone S. Nanthakumar N.N. Human milk oligosaccharides and synthetic galactosyloligosaccharides contain 3′-, 4-, and 6′-galactosyllactose and attenuate inflammation in human T84, NCM-460, and H4 cells and intestinal tissue ex vivo. J. Nutr. 2016 146 2 358 367 10.3945/jn.115.220749 26701795
    [Google Scholar]
  33. Vinderola G. Sanders M.E. Salminen S. Szajewska H. Postbiotics: The concept and their use in healthy populations. Front. Nutr. 2022 9 1002213 10.3389/fnut.2022.1002213 36570166
    [Google Scholar]
  34. Szajewska H. Skórka A. Pieścik-Lech M. Fermented infant formulas without live bacteria: A systematic review. Eur. J. Pediatr. 2015 174 11 1413 1420 10.1007/s00431‑015‑2629‑y 26358067
    [Google Scholar]
  35. Zagato E Mileti E Massimiliano L Lactobacillus paracasei CBA L74 metabolic products and fermented milk for infant formula have anti-inflammatory activity on dendritic cells in vitro and protective effects against colitis and an enteric pathogen in vivo. PLoS One 2014 9 2 e87615 10.1371/journal.pone.0087615
    [Google Scholar]
  36. Nocerino R. Paparo L. Terrin G. Pezzella V. Amoroso A. Cosenza L. Cecere G. De Marco G. Micillo M. Albano F. Nugnes R. Ferri P. Ciccarelli G. Giaccio G. Spadaro R. Maddalena Y. Berni Canani F. Berni Canani R. Cow’s milk and rice fermented with Lactobacillus paracasei CBA L74 prevent infectious diseases in children: A randomized controlled trial. Clin. Nutr. 2017 36 1 118 125 10.1016/j.clnu.2015.12.004 26732025
    [Google Scholar]
  37. Bäckhed F. Roswall J. Peng Y. Feng Q. Jia H. Kovatcheva-Datchary P. Li Y. Xia Y. Xie H. Zhong H. Khan M.T. Zhang J. Li J. Xiao L. Al-Aama J. Zhang D. Lee Y.S. Kotowska D. Colding C. Tremaroli V. Yin Y. Bergman S. Xu X. Madsen L. Kristiansen K. Dahlgren J. Wang J. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015 17 6 852 10.1016/j.chom.2015.05.012 26308884
    [Google Scholar]
  38. De Bernardo G D'Urso G Spadarella S Giordano M Leone G Casapullo A. Analysis of the fecal metabolomic profile in breast vs. Different formula milk feeding in late preterm infants. Metabolites 2024 14 1 72 10.3390/metabo14010072
    [Google Scholar]
  39. Liao Y Wu X Luo W Azelaic acid regulates the renin-angiotensin system and improves colitis based on network pharmacology and experimentation. ACS Omega 2023 8 17 15217 15228 10.1021/acsomega.3c00210
    [Google Scholar]
  40. Egan M Jiang H O'Connell Motherway M Oscarson S van Sinderen D. Glycosulfatase-encoding gene cluster in bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 2016 82 22 6611 6623 10.1128/AEM.02022‑16
    [Google Scholar]
  41. Kumar N Gupta G Anilkumar K 15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome. Sci. Rep. 2016 6 31649 10.1038/srep31649
    [Google Scholar]
/content/journals/cpr/10.2174/0115733963341570250422095946
Loading

  • Article Type:
    Review Article
Keywords: microbiota ; formula milk ; infant nutrition ; breast milk ; Post-biotic ; human milk ; fecal metabolome
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test